healthcare
healthcare Articles
Spectrum Pharma shares dipped on Thursday after the firm announced a key update from the FDA on its treatment of neutropenia in breast cancer patients.
Published:
Last Updated:
The December 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The December 14 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Published:
Last Updated:
Gritstone shares made a handy gain on Friday after the firm received a key update from the FDA.
Published:
Last Updated:
Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff.
Published:
Last Updated:
GlaxoSmithKline shares bounced higher on Wednesday after the company announced a new joint venture with Pfizer. These two firms will create a premier global consumer health care company combining...
Published:
Last Updated:
Tilray shares made a solid gain on Tuesday after the company announced that it entered a global agreement to collaborate with Sandoz, a subsidiary of Novartis.
Published:
Last Updated:
Proteostasis Therapeutics shares jumped on Monday after the company announced that a new licensing agreement with Genentech.
Published:
Last Updated:
A federal district court judge in Texas had declared the Affordable Care Act (aka, Obamacare) unconstitutional in a ruling that is taking a bite out of shares in insurance and hospital firms Monday.
Published:
Last Updated:
Eli Lilly shares were slightly lower after the company announced positive results from its late-stage active psoriatic arthritis study.
Published:
Last Updated:
Johnson & Johnson shares dropped on Friday after it came public that the company knew for decades that its baby powder sometimes contained the known carcinogen asbestos.
Published:
Last Updated:
Eli Lilly shares rose slightly on Thursday after the company announced an FDA update on its treatment for systemic lupus erythematosus.
Published:
Last Updated:
Applied Genetic Technologies shares dropped on Thursday after the company announced that its midstage eye study did not live up to expectations.
Published:
Last Updated:
Marinus shares backed off on Wednesday when the firm announced that it would be conducting a secondary offering. The company is capitalizing on its success earlier this week when it announced...
Published:
Last Updated:
Neurocrine Bio shares dipped on Wednesday after the company announced that its midstage Tourette syndrome study did not live up to expectations.
Published:
Last Updated: